Physician profile
David Gitlin
NPI 1336258417
$23,740.49
in general payments reported to CMS, 2019-2025
15 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $4,371 · 2021: $1,544 · 2022: $3,288 · 2023: $1,045 · 2024: $288 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20,427.59 | 2019-2024 | Augment Injectable, Ortholoc 2 Lapifuse, Variax |
| Gotham Surgical Solutions & Devices, INC. | $2,400.00 | 2021-2022 | |
| Kerecis Limited | $280.76 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $233.44 | 2022 | |
| Orthofix Medical, INC. | $97.01 | 2022-2023 | Spinal-Stim, Spinal-Stim |
| Treace Medical Concepts, INC. | $64.03 | 2023-2025 | |
| Paragon 28, INC. | $49.78 | 2025 | Mtp |
| Organogenesis INC. | $35.85 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $35.05 | 2022 | |
| Arthrex, INC. | $30.18 | 2024 | |
| Glaxosmithkline, LLC. | $19.90 | 2021 | |
| Bioventus LLC | $18.58 | 2025 | Exogen Ultrasound Bone Healing System |
| Allergan, INC. | $18.48 | 2019 | |
| Integra Lifesciences Corporation | $17.76 | 2019 | |
| Arthrosurface Incorporated | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gitlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.